Michael Wohlfahrt is an esteemed Adjunct Professor at Rutgers Business School, where he brings over 30 years of extensive experience in pharmaceutical operations, supply chain management, and project management to the classroom. His expertise lies in transforming complex challenges into actionable strategies, making him a...
Michael Wohlfahrt is an esteemed Adjunct Professor at Rutgers Business School, where he brings over 30 years of extensive experience in pharmaceutical operations, supply chain management, and project management to the classroom. His expertise lies in transforming complex challenges into actionable strategies, making him a valuable asset to both undergraduate and graduate students in the Supply Chain Management department. Michael’s teaching focuses on Project Management and Supply Chain Management, where he emphasizes the importance of innovative problem-solving and effective communication—skills he honed throughout his career in the pharmaceutical industry.
In his current role, Michael is dedicated to fostering the next generation of leaders in supply chain and project management. He engages students with real-world case studies, drawing from his extensive background in managing product launches, clinical trials, and quality assurance processes. His commitment to process improvement and validation is evident in his teaching style, as he encourages students to think critically about the complexities of supply chain dynamics and the regulatory environment governed by the U.S. Food and Drug Administration.
Michael’s approach to education is rooted in his belief that effective coaching and mentorship are essential for developing talent. He actively cultivates an environment where students can thrive, equipping them with the skills necessary to navigate the fast-paced pharmaceutical landscape. By integrating his industry insights with academic rigor, Michael Wohlfahrt not only enhances the learning experience at Rutgers Business School but also prepares his students to become high-performing leaders in their own right.
